Back to Search
KEITH MCBURNETT, PH.D.
PH.D.
Clinical Psychologist
NPI: 1790700631Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
PSY12510(CA)
Research & Publications (20)
A randomized, controlled trial of integrated home-school behavioral treatment for ADHD, predominantly inattentive type.
PMID 17667482·J Am Acad Child Adolesc Psychiatry·2007
2-rct
Mood and hormone responses to psychological challenge in adolescent males with conduct problems.
PMID 15866550·Biol Psychiatry·2005
3-trial
Antisocial personality, substance abuse, and exposure to parental violence in males referred for domestic violence.
PMID 11688925·Violence Vict·2001
8-other
Symptom properties as a function of ADHD type: an argument for continued study of sluggish cognitive tempo.
PMID 11411783·J Abnorm Child Psychol·2001
8-other
Low salivary cortisol and persistent aggression in boys referred for disruptive behavior.
PMID 10632231·Arch Gen Psychiatry·2000
8-other
Can executive functions explain the relationship between Attention Deficit Hyperactivity Disorder and social adjustment?
PMID 19184400·J Abnorm Child Psychol·2009
8-other
Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD.
PMID 19179940·CNS Spectr·2008
3-trial
A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
PMID 18166547·Pediatrics·2008
4-observational
Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
PMID 18315451·J Child Adolesc Psychopharmacol·2007
4-observational
Social skills differences among attention-deficit/hyperactivity disorder types in a chat room assessment task.
PMID 17354064·J Abnorm Child Psychol·2007
4-observational
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
PMID 16389216·Arch Pediatr Adolesc Med·2006
4-observational
Family correlates of comorbid anxiety disorders in children with attention deficit/hyperactivity disorder.
PMID 17039405·J Abnorm Child Psychol·2006
8-other
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
PMID 16768642·J Child Adolesc Psychopharmacol·2006
2-rct
Family correlates of oppositional and conduct disorders in children with attention deficit/hyperactivity disorder.
PMID 16195950·J Abnorm Child Psychol·2005
8-other
ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study.
PMID 16175106·J Am Acad Child Adolesc Psychiatry·2005
3-trial
The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K).
PMID 15004873·Yonsei Med J·2004
4-observational
ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
PMID 12649629·J Am Acad Child Adolesc Psychiatry·2003
3-trial
Waxing and waning in concert: dynamic comorbidity of conduct disorder with other disruptive and emotional problems over 7 years among clinic-referred boys.
PMID 12428769·J Abnorm Psychol·2002
8-other
Father absence and familial antisocial characteristics.
PMID 11695539·J Abnorm Child Psychol·2001
8-other
Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.
PMID 11581440·Pediatrics·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 401 PARNASSUS AVE
SAN FRANCISCO, CA 94143 - Phone
- (415) 476-7892
Quick Facts
- NPI
- 1790700631
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile